CAR T-cell implant effective at attacking cancer in pre-clinical study
Researchers have created an implantable biotechnology that produces and releases CAR T cells for attacking cancerous tumours.
List view / Grid view
Researchers have created an implantable biotechnology that produces and releases CAR T cells for attacking cancerous tumours.
NanoTemper Technologies has announced the launch of Spectral Shift technology with its Dianthus instrument.
Sino Biological, Inc. has announced a new contract research services partnership with Ainnocence, Inc.
Novel research has shown that morphological fingerprinting could help identify side effects of new bioactive compounds in drug discovery.
Scientists have created a pipeline for identifying, prioritising and evaluating potential tumour antigens for personalised cancer vaccines.
Scientists have discovered the essential role of a ligand-dependent corepressor to potentially enable cancer cells to present tumour antigens on their surfaces.
New research has discovered metabolic mechanisms that contribute to how ovarian cancer escapes from immune attack and how combination therapies can exploit these pathways to improve ovarian cancer treatment.
A next-generation spatial genomics technology has allowed scientists to link specific genes to complex tumour characteristics at a scale and resolution not previously possible.
Scientists from Northwestern University have developed a new technology platform that could bring individualised cell therapies to cancer patients.
In this exclusive piece, Adrien Châtillon, Co-Founder and CEO of Actipulse Neuroscience, explores the future of treatment for diseases that impact mental health.
A scientist at the University of Houston receives a $2 million grant to innovate computer-aided drug discovery for breast cancer.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.
A new study modelled chlamydia and HPV co-infection in patient-derived ectocervix organoids to reveal distinct cellular reprogramming.
New research by the University of California, San Diego could provide a much simpler way to repair disease-causing mutations in RNA.
In this Q&A, Professor Ross King from the University of Cambridge, UK, discusses how a new machine learning approach could aid drug discovery and development. The method learns from multiple problems and improves performance while it learns.